Gaucher Case Study – Ellie’s Story (type 2) Gaucher Case Study – Ellie’s Story (type 2)
  • News
  • Manifesto 2019
  • The UK Newborn Screening Collaborative
  • Charities
    • Gauchers Association
    • MPS Society
    • Niemann-Pick UK
    • The CATS Foundation
    • AGSD-UK
    • BDFA-UK
    • Krabbe UK
    • Pompe Support Network
    • MLD Support UK
    • Cystinosis Foundation UK
  • LSDs supported
    • Batten Disease
    • Cystinosis
    • Danon Disease
    • Fabry Disease
    • Farber disease
    • Fucosidosis
    • Gaucher disease
    • Geleophysic Dysplasia
    • GM-1 Gangliosidosis
    • Krabbe Disease
    • LAL D (Lysosomal Acid Lipase Deficiency) – Wolman, CESD
    • Mannosidosis
    • Metachromatic Leukodystrophy
    • Mucolipidosis
    • Mucolipidosis
    • MPS (Mucopolysaccharidosis)
    • Multiple Sulphatase Deficiency
    • Niemann-Pick Disease
    • Pompe Disease
    • Sandhoff Disease
    • Sialic Acid Storage Disease
    • Zellweger Syndrome
    • Tay Sachs Disease
    • Winchester Syndrome
  • Leaflets
    • About us
    • Virtual consultations
  • Contact
  • News
  • Manifesto 2019
  • The UK Newborn Screening Collaborative
  • Charities
    • Gauchers Association
    • MPS Society
    • Niemann-Pick UK
    • The CATS Foundation
    • AGSD-UK
    • BDFA-UK
    • Krabbe UK
    • Pompe Support Network
    • MLD Support UK
    • Cystinosis Foundation UK
  • LSDs supported
    • Batten Disease
    • Cystinosis
    • Danon Disease
    • Fabry Disease
    • Farber disease
    • Fucosidosis
    • Gaucher disease
    • Geleophysic Dysplasia
    • GM-1 Gangliosidosis
    • Krabbe Disease
    • LAL D (Lysosomal Acid Lipase Deficiency) – Wolman, CESD
    • Mannosidosis
    • Metachromatic Leukodystrophy
    • Mucolipidosis
    • Mucolipidosis
    • MPS (Mucopolysaccharidosis)
    • Multiple Sulphatase Deficiency
    • Niemann-Pick Disease
    • Pompe Disease
    • Sandhoff Disease
    • Sialic Acid Storage Disease
    • Zellweger Syndrome
    • Tay Sachs Disease
    • Winchester Syndrome
  • Leaflets
    • About us
    • Virtual consultations
  • Contact

gaucher

Gaucher Case Study – Ellie’s Story (type 2)

In this story Ellie’s father describes Ellie’s short life. Ellie had Type 2 Gaucher disease.

“It was Sunday the 6th of July 2003 at about 04.55 am when my wife Jill went into labour. As our son Cameron was only four years old we called my mum and said we would drop him off on the way to the hospital. We were all excited especially Cameron who could not wait to have a baby brother or sister.

At 07.01 am we had a beautiful blue eyed baby girl Eleanor Lily. As it turned out to be quite a  traumatic birth and Ellie was a bit dazed, she was taken to special baby care for observation, everything turned out to be fine or so we thought and she was released the next day. We were so happy and Cameron doted on here. Everything seemed to be perfect until early September, when as my dad was holding Ellie she seemed to stop breathing and turn blue. This was absolutely terrifying. We rushed straight to the hospital, where the doctors’ diagnosed reflux and our baby girl was prescribed gaviscon.

This was just the beginning, Ellie started to have seizures which became more frequent, eventually after being admitted to hospital to have more tests it was found our little girl was having problems swallowing so she was transferred to the Royal Victoria Infirmary in Newcastle. Ellie was put in the special care baby unit as it was thought her feeding and breathing tubes might be reversed so she had to have a bronocohosopy, this came back negative so we were back to square one.

On the 18th November 2003 the doctors suggested Ellie might have a metabolic disorder called Gaucher . “What was this” we said? Ellie would have to have a bone marrow biopsy as if she hadn’t been through enough.

On November 19th 2003, our son Cameron’s 5th birthday he stayed with us in the hospital so we could see him open his presents and see his baby sister. Little did we know this would be a day we would never forget. We received the most devastating news imaginable.

Our little angel Ellie had Type 2 Gaucher disease and she would only have a very short life.

The doctors suggested we keep Ellie in hospital but we knew instantly we wanted to take her home where we could care for her and feel some sort of normality, not just for us but Cameron as well. We obviously could not tell Cameron what was wrong with his baby sister but it’s as if he knew, he helped set her feeding machine up, give her medicine and even suction her, it was unbelievable.

The next months were the most heart breaking of our lives, even though she was terribly ill she still managed to smile and every time she heard her brother’s voice she would get excited.

Even though we were told the outcome of this terrible disease, we could not just do anything so we emailed every possible doctor imaginable from America to Israel, and also took Ellie to Great Ormond Street Hospital in the search for any sort of hope, but to no avail.

On the morning of the 9th February 2004 Ellie’s breathing became worse so we took her to our local hospital where we got the news we had dreaded. For the last three months her throat muscles had collapsed and there was nothing that could be done except try to make her as comfortable as possible. Later that day, with all her family present and in our arms, our precious little girl left us to be an angel.”

Read More

Gaucher Case Study – Mia’s Story (type 3)

“My name is Mia and I am 12 years old. I live with my Mum and Dad, sister Skye (9) and brother Josh (6). We have a dog called Toby. I have lots of interests including riding, on my special tricycle, swimming, cooking (my favourite) but most of all I love being with my friends and I have many!!

Just after my first birthday my Mummy and Daddy found out I had Type 3 Gaucher disease.”

Coming to terms with and coping with Mia’s condition were very challenging in the early days to say the least. She presented with classic neurological symptoms. Stunned, we were hurled reluctantly, into a world totally unfamiliar to us. (Nothing really prepares you). Hospital appointments which included, procedures and investigations became routine. We made frequent visits to Great Ormond Street and our local hospitals. In addition we saw physio -therapists, occupational therapists, dieticians, speech and language therapists etc. We undertook training quite early on so that we could give Mia her enzyme replacement therapy at home. We felt it was important to keep hospital visits to a minimum and keep life as normal as possible. The biggest challenge for Mia and our family came when, at the age of three she was invited to participate in a drug trial. It was a very stressful and as it turns out unsuccessful experiment.

Mia is affected by Gaucher in many ways. She has gross and fine motor skill problems due to stiffness and her general body tone. She is ataxic, has processing difficulties and has saccadic initiation failure (she can’t move her eyes from side to side). She had choking episodes and frequent chest infections when she was younger but has made great improvements in these areas. Mia whilst compromised is bright and very sociable. We’ve noted how she brings out the very best in everyone she meets. “She’s a real inspiration” we’re told frequently.

A few years ago a fourteen year old friend cycled from Hayling Island to Paris in order to raise awareness of Gaucher disease and money for a tricycle so that Mia could join us on bike rides. We are privileged to have friends who have run marathons, rowed oceans, held tennis tournaments, and a charity ball. Friends of Mia have made and sold cakes to raise awareness and funds to try to help beat this disease. We’ve met some incredibly special people. In particular families who like us have had to somehow draw on and identify the positives from an unfortunate situation.

Mia writes; “I now go to a school called St Anthony’s in Chichester which is about 25 minutes from my house. It is a school for people with moderate learning difficulties. I am doing so well there. In my first two terms I have won special awards for my achievements. I am very proud of this. It has an amazing indoor swimming pool; it has good sports facilities and a lovely art room. My favourite lessons are art, drama and cookery. I can do all these things but I find PE the most difficult. This is because my balance is not good and I find it difficult to run but I always try my best at everything. My mummy says that although I have an unfortunate condition I am lucky because I am such a positive person with a great attitude to life and get so much enjoyment from everything I do”.

Read More

Gaucher Case Study – Liam’s Story (type 1)

I ‘got’ Gaucher Disease for my 40th birthday in 1992 and, in a perverse way; it has turned out to be the best ‘birthday present’ I ever got.

Having presented to my GP in Dublin with extreme tiredness, which I attributed to a combination of heavy smoking and too-long hours working to run a struggling technology company, he advised me see a haematologist as my blood counts were ‘all over the place’. Several visits later and my still mystified haematologist referred me to Prof. Cox and his team at Addenbrooke’s. They confirmed that I had Gaucher disease, something neither I nor my haematologist had ever encountered. The ‘good news’ was that it was Type 1 and had only started to ‘kick in’ and it would another 5-10 years before it really started to impact on me by which time, a treatment, then being trialled, would most likely be available.

Twice a year since, I have been attending Addenbrooke’s for monitoring; and in 1997, they advised that I needed to start treatment as my condition was deteriorating. At this stage I was getting bone crises, my spleen was 16 times larger than normal and I could hardly go an hour without feeling exhausted. After prolonged negotiation and with the assistance of Prof Cox, we finally managed, in September 1998, to get approval from the Irish Health authorities for administration of Cererdase, the first Irish patient to do so.

I had to retire from my job as it was expected that it would take up to two years for the treatment to work, if at all. And this, as much as my medical condition, was a huge shock to my system, which I found very difficult to cope with. I also had the worry of how to provide for a family of 6 children ranging in age from 25 to 7 and my former wife. Fortunately, within 6 months, my condition had stopped worsening and within 18 months I was declared well enough to return to ‘sedentary’ work.

During that recovery time, I had something of an epiphany and vowed that I was not going to waste my reprieve chasing the corporate dollar. I set up a small consultancy with the specific aim of working just enough to pay the basics, having by now realised how little one really needs to get by (especially if you have a supportive partner; now my wonderful second wife). I worked hours that suited me, mostly on projects that interested me and only with people I liked; thus freeing me to pursue other long-held but frustrated ambitions, most of which I have gone a long way to fulfilling over the past decade. I have had time to spend with my family, including several grandchildren. I have been able to give something back through volunteering with my local Credit Union and charities for the elderly and have, through working with Habitat for Humanity, helped build houses for disadvantaged communities in such exotic places as India, Kyrgyzstan, El Salvador and Chile. My time on golf courses has increased immeasurably, though not my scores! And I have been able to indulge my passion for the outdoors through innumerable Hill-walking trips with a local club.

I still need Cerezyme infusions every fortnight but I see it as a minor but necessary inconvenience.

Life is good and I’m greedy for lots more of it. So thank you Gaucher! More particularly, thanks to the geeks of medical science and the wonderful teams at Addenbrooke’s and Dublin’s Mater and last but not least, the Gaucher Association whose support, especially in those dark distant pre-internet days, was invaluable in keeping me informed.

Read More

Charity Profile – The Gauchers Association

Gauchers Association (small 2)

The Gauchers Association was formed in 1991, and is the only organisation in the United Kingdom that provides information and support to those with Gaucher disease, their families and health-care professionals.

The Association:

  • Supports families and carers to ensure all individuals with Gaucher disease have access to best practice in diagnosis, treatment and care.
  • Provides information on Gaucher disease and raises awareness of this rare disease.
  • Promotes research into the causes, effects and treatments of Gaucher disease.
  • Represents the interests of Gaucher patients at all times to ensure that the voice of the
  • Gaucher patient is heard.

What is Gaucher disease?

Gaucher disease is a genetically inherited, enzyme deficiency disorder. Symptoms range from mild to severe and can appear at any time, from infancy to old age. They may include anaemia, fatigue, easy bruising and a tendency to bleed. An enlarged spleen and liver with a protruding stomach may also occur as well as bone pain, demineralisation and fractures.

People with Gaucher disease lack sufficient activity levels of an enzyme called glucocerebrosidase.
This Enzyme helps the body break down worn-out cells and as a result, a fatty substance called glucocerebroside accumulates in the spleen, liver, bone marrow and sometimes in the central nervous system.

The most common form of Gaucher Disease (Type 1) affects 1 in 100,000 of the general population but 1 in 850 of Jewish (Ashkenazi) descent, although not all those who inherit the mutated genes for this disorder will show symptoms.

In the rare Neuronopathic (Types 2 and 3) Gaucher Disease, neurological symptoms occur which include an eye movement disorder (oculomotor apraxia), unsteadiness (ataxia), fits, loss of skills and a central auditory processing disorder. Children with Type 2 Gaucher disease die within one or two years of birth.

Read More

Recent Posts

  • International Gaucher Alliance Projects Officer Role
  • The COVID 19 Vaccine and Inherited Metabolic Disease Webinar – What You Need to Know
  • COVID-19 and its impact on inherited metabolic diseases webinar
  • Inherited Metabolic Disease and Coronavirus – Updated information for Patients, Parents and Guardians – 16 MARCH 2020
  • LSD Collaborative 2018 WORLD poster

Recent Comments

    Archives

    • May 2021
    • February 2021
    • March 2020
    • February 2018
    • August 2014
    • July 2014
    • June 2014
    • April 2014
    • March 2014
    • January 2014

    Categories

    • announcement
    • case study
    • charity
    • conference
    • events
    • projects
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    © 2019 The UK LSD Patient Collaborative. All right reserved.
    Theme By DankovThemes